Physician Wealth Advisors’s Advanced Micro Devices AMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Sell
2,820
-476
-14% -$195K 0.2% 61
2026
Q1
$670K Sell
3,296
-1,003
-23% -$214K 0.09% 88
2025
Q4
$921K Buy
4,299
+99
+2% +$22.2K 0.13% 72
2025
Q3
$680K Buy
4,200
+1,075
+34% +$173K 0.1% 85
2025
Q2
$443K Buy
3,125
+65
+2% +$7.08K 0.07% 107
2025
Q1
$314K Sell
3,060
-139
-4% -$15.5K 0.05% 131
2024
Q4
$386K Sell
3,199
-916
-22% -$132K 0.07% 116
2024
Q3
$645K Buy
4,115
+210
+5% +$31.9K 0.12% 80
2024
Q2
$693K Buy
3,905
+108
+3% +$17.4K 0.13% 78
2024
Q1
$621K Buy
3,797
+128
+3% +$22.4K 0.13% 82
2023
Q4
$617K Buy
3,669
+1,000
+37% +$118K 0.14% 77
2023
Q3
$286K Sell
2,669
-5
-0.2% -$543 0.07% 108
2023
Q2
$310K Hold
2,674
0.08% 107
2023
Q1
$241K Buy
+2,674
New +$218K 0.06% 134
2022
Q3
Sell
-2,674
Closed -$259K 147
2022
Q2
$259K Hold
2,674
0.08% 125
2022
Q1
$266K Buy
+2,674
New +$319K 0.07% 131

Other funds holding AMD

Physician Wealth Advisors's AMD Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Advanced Micro Devices (AMD) stake by 14% in Q2 2026, selling an estimated $195K and leaving 2,820 shares worth $1.64M. The position accounts for 0.2% of the portfolio, ranked #61.

Physician Wealth Advisors first reported a position in AMD in Q1 2022 and has held it in 16 quarters since. 3,986 funds tracked by Wall St. Rank hold AMD as of Q2 2026.

  • Physician Wealth Advisors held 2,820 shares of Advanced Micro Devices worth $1.64M as of Q2 2026.
  • Physician Wealth Advisors sold 476 Advanced Micro Devices shares in Q2 2026, an estimated $195K.
  • Advanced Micro Devices made up 0.2% of Physician Wealth Advisors's portfolio in Q2 2026, its #61 holding.
  • Physician Wealth Advisors first reported a position in Advanced Micro Devices in Q1 2022 and has held it in 16 quarters since.
  • 3,986 funds tracked by Wall St. Rank held Advanced Micro Devices as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.